202 related articles for article (PubMed ID: 38048087)
1. Neuronally Derived Extracellular Vesicle α-Synuclein as a Serum Biomarker for Individuals at Risk of Developing Parkinson Disease.
Yan S; Jiang C; Janzen A; Barber TR; Seger A; Sommerauer M; Davis JJ; Marek K; Hu MT; Oertel WH; Tofaris GK
JAMA Neurol; 2024 Jan; 81(1):59-68. PubMed ID: 38048087
[TBL] [Abstract][Full Text] [Related]
2. Detection of α-synuclein in CSF by RT-QuIC in patients with isolated rapid-eye-movement sleep behaviour disorder: a longitudinal observational study.
Iranzo A; Fairfoul G; Ayudhaya ACN; Serradell M; Gelpi E; Vilaseca I; Sanchez-Valle R; Gaig C; Santamaria J; Tolosa E; Riha RL; Green AJE
Lancet Neurol; 2021 Mar; 20(3):203-212. PubMed ID: 33609478
[TBL] [Abstract][Full Text] [Related]
3. Serum MicroRNAs Predict Isolated Rapid Eye Movement Sleep Behavior Disorder and Lewy Body Diseases.
Soto M; Iranzo A; Lahoz S; Fernández M; Serradell M; Gaig C; Melón P; Martí MJ; Santamaría J; Camps J; Fernández-Santiago R; Ezquerra M
Mov Disord; 2022 Oct; 37(10):2086-2098. PubMed ID: 35962561
[TBL] [Abstract][Full Text] [Related]
4. Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional study.
Siderowf A; Concha-Marambio L; Lafontant DE; Farris CM; Ma Y; Urenia PA; Nguyen H; Alcalay RN; Chahine LM; Foroud T; Galasko D; Kieburtz K; Merchant K; Mollenhauer B; Poston KL; Seibyl J; Simuni T; Tanner CM; Weintraub D; Videnovic A; Choi SH; Kurth R; Caspell-Garcia C; Coffey CS; Frasier M; Oliveira LMA; Hutten SJ; Sherer T; Marek K; Soto C;
Lancet Neurol; 2023 May; 22(5):407-417. PubMed ID: 37059509
[TBL] [Abstract][Full Text] [Related]
5. Accurate Detection of α-Synuclein Seeds in Cerebrospinal Fluid from Isolated Rapid Eye Movement Sleep Behavior Disorder and Patients with Parkinson's Disease in the DeNovo Parkinson (DeNoPa) Cohort.
Concha-Marambio L; Weber S; Farris CM; Dakna M; Lang E; Wicke T; Ma Y; Starke M; Ebentheuer J; Sixel-Döring F; Muntean ML; Schade S; Trenkwalder C; Soto C; Mollenhauer B
Mov Disord; 2023 Apr; 38(4):567-578. PubMed ID: 36781413
[TBL] [Abstract][Full Text] [Related]
6. Neurodegenerative disease status and post-mortem pathology in idiopathic rapid-eye-movement sleep behaviour disorder: an observational cohort study.
Iranzo A; Tolosa E; Gelpi E; Molinuevo JL; Valldeoriola F; Serradell M; Sanchez-Valle R; Vilaseca I; Lomeña F; Vilas D; Lladó A; Gaig C; Santamaria J
Lancet Neurol; 2013 May; 12(5):443-53. PubMed ID: 23562390
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal analyses of cerebrospinal fluid α-Synuclein in prodromal and early Parkinson's disease.
Mollenhauer B; Caspell-Garcia CJ; Coffey CS; Taylor P; Singleton A; Shaw LM; Trojanowski JQ; Frasier M; Simuni T; Iranzo A; Oertel W; Siderowf A; Weintraub D; Seibyl J; Toga AW; Tanner CM; Kieburtz K; Chahine LM; Marek K; Galasko D;
Mov Disord; 2019 Sep; 34(9):1354-1364. PubMed ID: 31361367
[TBL] [Abstract][Full Text] [Related]
8. Idiopathic rapid eye movement sleep behavior disorder in Japan: An observational study.
Nishikawa N; Murata M; Hatano T; Mukai Y; Saitoh Y; Sakamoto T; Hanakawa T; Kamei Y; Tachimori H; Hatano K; Matsuda H; Taruno Y; Sawamoto N; Kajiyama Y; Ikenaka K; Kawabata K; Nakamura T; Iwaki H; Kadotani H; Sumi Y; Inoue Y; Hayashi T; Ikeuchi T; Shimo Y; Mochizuki H; Watanabe H; Hattori N; Takahashi Y; Takahashi R;
Parkinsonism Relat Disord; 2022 Oct; 103():129-135. PubMed ID: 36113390
[TBL] [Abstract][Full Text] [Related]
9. Dermal phospho-alpha-synuclein deposits confirm REM sleep behaviour disorder as prodromal Parkinson's disease.
Doppler K; Jentschke HM; Schulmeyer L; Vadasz D; Janzen A; Luster M; Höffken H; Mayer G; Brumberg J; Booij J; Musacchio T; Klebe S; Sittig-Wiegand E; Volkmann J; Sommer C; Oertel WH
Acta Neuropathol; 2017 Apr; 133(4):535-545. PubMed ID: 28180961
[TBL] [Abstract][Full Text] [Related]
10. α-synuclein antibody 5G4 identifies idiopathic REM-sleep behavior disorder in abdominal skin biopsies.
Tóth Š; Kulcsárová K; Maretta M; Kunová A; Mechírová E; Gdovinová Z; Feketeová E; Ribeiro Ventosa J; Baloghová J; Bekeová M; Christová P; Mrázová S; Muránska S; Zeidan D; Škorvánek M
Parkinsonism Relat Disord; 2024 Mar; 120():105956. PubMed ID: 38217955
[TBL] [Abstract][Full Text] [Related]
11. Validation of α-Synuclein in L1CAM-Immunocaptured Exosomes as a Biomarker for the Stratification of Parkinsonian Syndromes.
Jiang C; Hopfner F; Berg D; Hu MT; Pilotto A; Borroni B; Davis JJ; Tofaris GK
Mov Disord; 2021 Nov; 36(11):2663-2669. PubMed ID: 33826157
[TBL] [Abstract][Full Text] [Related]
12. Characterization of patients with longstanding idiopathic REM sleep behavior disorder.
Iranzo A; Stefani A; Serradell M; Martí MJ; Lomeña F; Mahlknecht P; Stockner H; Gaig C; Fernández-Arcos A; Poewe W; Tolosa E; Högl B; Santamaria J;
Neurology; 2017 Jul; 89(3):242-248. PubMed ID: 28615430
[TBL] [Abstract][Full Text] [Related]
13. α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study.
Mollenhauer B; Locascio JJ; Schulz-Schaeffer W; Sixel-Döring F; Trenkwalder C; Schlossmacher MG
Lancet Neurol; 2011 Mar; 10(3):230-40. PubMed ID: 21317042
[TBL] [Abstract][Full Text] [Related]
14. Validation of the MDS research criteria for prodromal Parkinson's disease: Longitudinal assessment in a REM sleep behavior disorder (RBD) cohort.
Fereshtehnejad SM; Montplaisir JY; Pelletier A; Gagnon JF; Berg D; Postuma RB
Mov Disord; 2017 Jun; 32(6):865-873. PubMed ID: 28429825
[TBL] [Abstract][Full Text] [Related]
15. Misfolded α-Synuclein Assessment in the Skin and CSF by RT-QuIC in Isolated REM Sleep Behavior Disorder.
Iranzo A; Mammana A; Muñoz-Lopetegi A; Dellavalle S; Mayà G; Rossi M; Serradell M; Baiardi S; Arqueros A; Quadalti C; Perissinotti A; Ruggeri E; Cano JS; Gaig C; Parchi P
Neurology; 2023 May; 100(18):e1944-e1954. PubMed ID: 36931726
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal change in dopamine transporter availability in idiopathic REM sleep behavior disorder.
Shin JH; Lee JY; Kim YK; Shin SA; Kim H; Nam H; Jeon B
Neurology; 2020 Dec; 95(23):e3081-e3092. PubMed ID: 32989104
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical Detection of Synuclein Pathology in Skin in Idiopathic Rapid Eye Movement Sleep Behavior Disorder and Parkinsonism.
Al-Qassabi A; Tsao TS; Racolta A; Kremer T; Cañamero M; Belousov A; Santana MA; Beck RC; Zhang H; Meridew J; Pugh J; Lian F; Robida MD; Ritter M; Czech C; Beach TG; Pestic-Dragovich L; Taylor KI; Zago W; Tang L; Dziadek S; Postuma RB
Mov Disord; 2021 Apr; 36(4):895-904. PubMed ID: 33232556
[TBL] [Abstract][Full Text] [Related]
18. α-Synuclein aggregates in labial salivary glands of idiopathic rapid eye movement sleep behavior disorder.
Iranzo A; Borrego S; Vilaseca I; Martí C; Serradell M; Sánchez-Valle R; Kovacs GG; Valldeoriola F; Gaig C; Santamaria J; Tolosa E; Gelpi E
Sleep; 2018 Aug; 41(8):. PubMed ID: 29790977
[TBL] [Abstract][Full Text] [Related]
19. SNCA Hypomethylation in Rapid Eye Movement Sleep Behavior Disorder Is a Potential Biomarker for Parkinson's Disease.
Zhao A; Li Y; Niu M; Li G; Luo N; Zhou L; Kang W; Liu J
J Parkinsons Dis; 2020; 10(3):1023-1031. PubMed ID: 32444558
[TBL] [Abstract][Full Text] [Related]
20. FDG PET, dopamine transporter SPECT, and olfaction: Combining biomarkers in REM sleep behavior disorder.
Meles SK; Vadasz D; Renken RJ; Sittig-Wiegand E; Mayer G; Depboylu C; Reetz K; Overeem S; Pijpers A; Reesink FE; van Laar T; Heinen L; Teune LK; Höffken H; Luster M; Kesper K; Adriaanse SM; Booij J; Leenders KL; Oertel WH
Mov Disord; 2017 Oct; 32(10):1482-1486. PubMed ID: 28734065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
